Vanguard Group Inc Ionis Pharmaceuticals Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 16,472,539 shares of IONS stock, worth $526 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,472,539
Previous 15,055,758
9.41%
Holding current value
$526 Million
Previous $603 Million
4.52%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
140MCall Options Held
829KPut Options Held
789K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$453 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$366 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$330 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$277 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$251 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.54B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...